"10.1371_journal.pone.0096993","plos one","2014-05-13T00:00:00Z","Federico Ambrogi; Marco Fornili; Patrizia Boracchi; Marco Trerotola; Valeria Relli; Pasquale Simeone; Rossana La Sorda; Rossano Lattanzio; Patrizia Querzoli; Massimo Pedriali; Mauro Piantelli; Elia Biganzoli; Saverio Alberti","Unit of Medical Statistics, Biometry and Bioinformatics Giulio A. Maccacaro, Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy; Unit of Cancer Pathology, Department of Biomedical Sciences and CeSI, Fondazione G. DAnnunzio, University of Chieti, Chieti, Italy; MediaPharma s.r.l., CeSI, University G. DAnnunzio, Chieti, Italy; Section of Surgical Pathology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; Fondazione IRCCS, Istituto Nazionale Tumori, Milano, Italy; Department of Neurosciences, Imaging and Clinical Sciences – Physiology and Physiopathology, University of Chieti, Chieti, Italy; Oncoxx Biotech s.r.l., Chieti, Italy","Conceived and designed the experiments: SA. Performed the experiments: VR PS MT RLS RL. Analyzed the data: PQ RL M. Pedriali FA MF PB EB M. Piantelli. Wrote the paper: FA EB SA. Managed the revision of the manuscript: MT.","This study was partly funded by Oncoxx Biotech, and Dr. Saverio Alberti is President of this company. This affiliation does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. A patent related to this work is Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors – PCT/IT2009/000035.","2014","05","Federico Ambrogi","FA",13,TRUE,1,5,3,3,TRUE,FALSE,TRUE,1,"3",FALSE
